Quick Answer: Treatment-resistant depression means depression hasn’t improved enough after standard treatment, often after at least two adequate antidepressant trials. If antidepressants aren’t working, the next step is usually to reassess the diagnosis, treatment history, therapy fit, safety needs, and whether more specialized care may be appropriate.
There are several common reasons for antidepressants not working as hoped, and most have nothing to do with the person not trying hard enough.
What Does Treatment-Resistant Depression Mean?
Treatment-resistant depression usually refers to depression that hasn’t improved enough after multiple appropriate treatment attempts. Many clinicians use lack of remission after two or more antidepressant trials, taken at an adequate dose and duration, as a common benchmark, although definitions can vary by provider, study, or health system.
The phrase can sound final, but it shouldn’t be read as “untreatable depression.” It means the treatment tried so far hasn’t produced enough relief, and the clinical picture needs a more careful look.
That distinction matters for people who feel exhausted by repeated appointments, medication changes, and partial improvement. Treatment resistance isn’t a character flaw, and it doesn’t mean the person has failed care. It means the care plan may need to become more precise.
Why Might Depression Treatment Not Be Working?
When depression persists, the first useful step isn’t always adding something new. Sometimes the most important work is understanding why previous care didn’t help enough.
The Medication Trial May Not Have Been Complete
A medication may not have been taken long enough, consistently enough, or at a dose the prescriber considered adequate. Sometimes a treatment was stopped because of side effects before anyone could tell whether it might help.
Side Effects or Access Barriers May Have Gotten in the Way
Nausea, sleep changes, emotional blunting, sexual side effects, cost, confusion about dosing, or missed refills can all affect whether a treatment had a fair trial. These details matter because they change what “didn’t work” really means.
The Diagnosis May Need Another Look
Depression that doesn’t respond as expected may need reassessment for bipolar disorder, trauma, anxiety, psychosis, grief, persistent depressive disorder, thyroid problems, chronic pain, sleep disorders, or medication effects.
The Therapy Fit May Not Have Been Right
Someone may have tried therapy, but not the right modality, frequency, intensity, or therapeutic relationship. Weekly talk therapy may not be enough when depression is severe, long-lasting, or tied to trauma, isolation, or functional decline.
The Level of Care May Not Match the Severity
Some people are trying to recover with tools that are too limited for the severity of their symptoms. If depression is disrupting sleep, meals, hygiene, work, relationships, medication consistency, or safety, standard outpatient care may not create enough structure.
This is why a careful review can be more helpful than simply asking, “What medication comes next?” The better question is what the person has tried, what happened, what was missed, and what level of support is needed now.
What Treatment-Resistant Depression Options Are Available?
The right plan depends on each person’s diagnosis, prior response, side effects, medical history, safety, and current functioning. There is no single next step that fits everyone, but there are several treatment resistant depression options clinicians may consider.
- Medication changes: A prescriber may adjust the dose, switch antidepressants, or consider a different medication class. This is most useful when the previous trial was incomplete, poorly tolerated, or only partially effective.
- Augmentation: If there was some response but not enough relief, another medication may be added to strengthen the effect or address symptoms that are still active. This requires careful monitoring, especially when depression is complex or side effects have been difficult.
- Psychotherapy changes: Therapy may need to become more targeted, more frequent, or more closely coordinated with psychiatry. For some people, the next step isn’t just “more therapy,” but a different therapeutic approach or a more structured treatment setting.
- Advanced treatments: Options such as transcranial magnetic stimulation (TMS), ketamine, esketamine, and electroconvulsive therapy (ECT) may be considered in some cases and are covered below.
- Higher levels of care: Residential or inpatient mental health treatment may be appropriate when depression is persistent, complex, unsafe, or not improving with routine outpatient appointments.
The goal isn’t to collect as many treatments as possible. The goal is to match the next step to the actual reason depression isn’t improving.
Is TMS an Option for Treatment-Resistant Depression?
TMS, or transcranial magnetic stimulation, is a noninvasive treatment that uses magnetic pulses to stimulate targeted brain areas involved in mood regulation.
For someone with treatment-resistant major depressive disorder, TMS may be considered when medication hasn’t helped enough or side effects have made medication difficult to continue. It isn’t the right fit for every person, and candidacy depends on diagnosis, medical history, symptom severity, prior treatment response, and provider evaluation.
TMS isn’t automatically a better choice than other options. It is one possible next step within a broader psychiatric plan, weighed alongside medication, therapy, and the level of care a person needs.
What About Ketamine, Esketamine, or ECT?
Ketamine, esketamine, and ECT, or electroconvulsive therapy, often come up when people search for what remains after standard depression treatment hasn’t worked. They are important to mention, but they should be understood as specialized options that require clinical evaluation.
Ketamine
Ketamine is a medication that has been used in medical settings for decades and is sometimes used off-label as a treatment for depression, particularly when standard treatments haven’t been effective. Unlike esketamine, ketamine isn’t FDA-approved specifically for depression. When considered for depression, it may be administered in a clinical setting under the supervision of a qualified medical professional.
Because ketamine can cause effects such as sedation, dissociation, and changes in blood pressure, treatment requires appropriate screening, monitoring, and follow-up. A psychiatrist or other qualified clinician can determine whether ketamine is appropriate based on a person’s symptoms, medical history, and overall treatment plan.
Esketamine
Esketamine is a medication derived from ketamine and is FDA-approved as a nasal spray for adults with treatment-resistant depression. It must be administered in a certified healthcare setting under supervision because of potential risks, including sedation, dissociation, and respiratory depression. Patients are monitored for at least two hours after each treatment session.
Although ketamine and esketamine are related, they aren’t interchangeable. They differ in their FDA approval status, formulation, route of administration, and treatment protocols. A psychiatrist can explain whether esketamine may be clinically appropriate and how it fits with the rest of a person’s treatment plan.
Electroconvulsive Therapy
Electroconvulsive therapy may be considered for severe depression, particularly when symptoms are life-threatening, psychotic, catatonic, or not responding to other treatment. ECT is often misunderstood, so it should be discussed with a qualified psychiatric team rather than judged by older cultural images of the treatment.
These options don’t mean someone has reached the end of care. They mean the depression may need a more specialized psychiatric approach.
When Does Depression Need More Than Weekly Outpatient Care?
Depression may need more than weekly outpatient care when the person’s life keeps getting smaller despite repeated treatment attempts.
The concern may not be one dramatic crisis. It may be the slow accumulation of days where the person can’t get out of bed, shower, eat consistently, answer messages, attend work, manage medication, or stay connected to people who care about them.
A person may need a higher level of care because medication changes need closer observation than occasional appointments can provide. Someone may benefit from a more intensive form of treatment if they have tried several medications, had difficult side effects, stopped treatment repeatedly, or feel too depleted to follow through with outpatient recommendations.
For some people, treatment-resistant depression also comes with self-neglect, chronic suicidal thoughts, major sleep disruption, isolation, or a sense that basic routines are no longer possible. In those cases, the next question is not only which treatment to try, but whether the person has enough daily support to actually receive care, stay safe, and begin stabilizing.
If someone is in immediate danger, call 911 or go to the nearest emergency room. You can also call or text 988 for crisis support.
How Neurish Wellness Supports Complex Depression
Neurish Wellness works with adults whose depression has become too complex for a simple medication change or once-a-week appointment to address. Care begins by looking more closely at diagnosis, medication response, therapy needs, daily functioning, family context, and the level of support required to move toward stability.
- Residential treatment for depression provides a structured setting for adults who may benefit from stepping away from daily stressors and receiving consistent psychiatric and therapeutic support. This may be especially helpful when depression has continued despite outpatient treatment or when daily functioning has significantly declined.
- Outpatient mental health treatment offers ongoing therapy, medication management, and clinical support while allowing adults to continue living at home.
- Virtual IOP provides a more flexible option for people who don’t need 24-hour support but may need more intensive care than weekly therapy. The virtual IOP allows clients to receive structured treatment remotely while continuing to live at home.
Every treatment plan is matched to each person’s diagnosis, safety, functioning, and treatment history.
You don’t have to navigate mental health care alone. Contact us today.
FAQs About Treatment-Resistant Depression
How many medications do you have to try before depression is treatment-resistant?
Many clinicians use two adequate antidepressant trials as a common benchmark, but definitions can vary. The quality of each trial matters, including dose, duration, consistency, side effects, and whether the diagnosis was complete.
How long does it take to know if a new depression treatment is working?
It varies by treatment. Many antidepressants need several weeks at an adequate dose before a prescriber can judge whether they are helping, which is one reason trials are sometimes stopped too early. A psychiatrist can explain what a fair trial looks like for the specific option being tried.
Should I stop my antidepressant if it doesn't seem to be working?
Not on your own. Stopping an antidepressant suddenly can cause withdrawal symptoms or a worsening of mood. If a medication doesn’t seem to be helping, the safer step is to talk with the prescriber about adjusting the dose, switching, or adding support rather than stopping abruptly.
Is treatment-resistant depression always severe?
Not always, but it can become severe when symptoms persist for a long time, impair daily life, or increase safety concerns. The level of care should match the person’s actual symptoms and functioning.
Can treatment-resistant depression improve and then come back?
Yes. Symptoms can improve and later return, which is why relapse prevention, consistent follow-up, and medication monitoring are part of long-term care. A return of symptoms doesn’t mean treatment failed. It usually means the plan needs another adjustment.
© Mental Health House, LLC DBA Neurish Wellness
CONTACT US
Phone: (866) 525 5197
Email: info@neurishwellness.com
Privacy Policy | Blog | Rehab for Professionals
[license_text]
